These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9202897)

  • 1. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Dalla Palma P
    Cytopathology; 1997 Jun; 8(3):210. PubMed ID: 9202897
    [No Abstract]   [Full Text] [Related]  

  • 2. Achievable standards, benchmarks for reporting and criteria for evaluating cervical cytopathology.
    Herbert A; Johnson J; Patnick J
    Cytopathology; 1995 Oct; 6(5):301-3. PubMed ID: 8785367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An operative model: verification of the quality of the screening Pap test ].
    Montanari GR; Arnaud S; Berardengo E; Campione D; Cozzani C; Parisio F; Viberti L; Ghiringhello B
    Pathologica; 2001 Oct; 93(5):609-10. PubMed ID: 11725370
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing terminology and screening recommendations in cervical cytology screening programs.
    Robertson DI; Srivannaboon S; Pairwuti S
    J Med Assoc Thai; 1992 Jan; 75 Suppl 1():90-3. PubMed ID: 1402489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity of primary screening by rapid review: 'to act or not to act on the results, that is the question'.
    Slater DN
    Cytopathology; 1998 Apr; 9(2):77-83. PubMed ID: 9577733
    [No Abstract]   [Full Text] [Related]  

  • 7. Cervical Cytology Practice Guidelines. American Society of Cytopathology.
    Cortese C;
    Acta Cytol; 2001; 45(2):201-26. PubMed ID: 11284307
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommended code of practice for laboratories providing a cytopathology service 1997. British Society for Clinical Cytology.
    Cytopathology; 1997 Jun; 8 Suppl 1():1-25. PubMed ID: 9202905
    [No Abstract]   [Full Text] [Related]  

  • 9. Internal quality control for cervical cytopathology laboratories.
    Coleman DV
    Cytopathology; 1996 Feb; 7(1):1-3. PubMed ID: 8833867
    [No Abstract]   [Full Text] [Related]  

  • 10. Papanicolaou Society of Cytopathology guidelines for educational notes, disclaimers, and similar comments on reports of cervical cytology specimens.
    Papanicolau Society of Cytopathology Practice Guidelines Task Force
    Diagn Cytopathol; 2003 May; 28(5):282-5. PubMed ID: 12722126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid review.
    Faraker CA
    Cytopathology; 1998 Apr; 9(2):71-6. PubMed ID: 9660635
    [No Abstract]   [Full Text] [Related]  

  • 12. Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. Second edition including revised performance indicators.
    Johnson EJ; Patnick J;
    Cytopathology; 2000 Aug; 11(4):212-41. PubMed ID: 10983723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of cervical screening in an inner city area--lessons for a national programme.
    Herity B; McDonald P; Johnson Z; Carroll B; Cody M; Duignan N; McGee D; O'Kelly F; Hurley M
    Cytopathology; 1997 Jun; 8(3):161-70. PubMed ID: 9202891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European guidelines on cervical screening.
    Smith JH; Desai MS
    Cytopathology; 2007 Aug; 18(4):211-2. PubMed ID: 17635160
    [No Abstract]   [Full Text] [Related]  

  • 15. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 16. High prevalence of human papillomavirus and cervical intraepithelial neoplasia in a young Australian STD population.
    McKinnon KJ; Ford RM; Hunter JC
    Int J STD AIDS; 1991; 2(4):276-9. PubMed ID: 1655057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial rescreening of all negative smears: an improved method of quality assurance in laboratories undertaking cervical screening.
    Faraker CA
    Cytopathology; 1993; 4(1):47-50. PubMed ID: 8453016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of working party on internal quality control for cervical cytopathology laboratories summary and recommendations.
    Cytopathology; 1996 Feb; 7(1):4-9. PubMed ID: 8833868
    [No Abstract]   [Full Text] [Related]  

  • 19. [The European aptitude test for cervical cytopathology].
    Branca M
    Pathologica; 2001 Feb; 93(1):28-33. PubMed ID: 11294016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of physical findings in diagnosis of cervical carcinoma.
    Moller KA; Fogh H; Moller PE; Strandbygard K
    Dan Med Bull; 1972 Jun; 19(4):122-7. PubMed ID: 5041568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.